Treatment of Intracranial Vasospasm Following Subarachnoid Hemorrhage
Vasospasm has been a long known source of delayed morbidity and mortality in aneurysmal subarachnoid hemorrhage patients. Delayed ischemic neurologic deficits associated with vasospasm may account for as high as 50% of the deaths in patients who survive the initial period after aneurysm rupture and...
Main Authors: | Andrew Michael Bauer, Peter eRasmussen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00072/full |
Similar Items
-
Safety and efficacy of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage induced vasospasm
by: Jonathan M. Parish, et al.
Published: (2021-06-01) -
Management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage
by: Mohamed Shehabeldin, et al.
Published: (2017-07-01) -
The Effect of a Single dose Dantrolene in Patients with Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
by: Masih Sabouri, et al.
Published: (2017-01-01) -
Hyponatremia as predictor of symptomatic vasospasm in aneurysmal subarachnoid hemorrhage
by: Faisal Alabbas, et al.
Published: (2020-12-01) -
Angiopoietin-1 is associated with cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage
by: Pfausler Bettina, et al.
Published: (2011-05-01)